194 related articles for article (PubMed ID: 21036750)
1. Assessing risk and mortality of venous thromboembolism in pancreatic cancer patients.
Shaib W; Deng Y; Zilterman D; Lundberg B; Saif MW
Anticancer Res; 2010 Oct; 30(10):4261-4. PubMed ID: 21036750
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor.
Delluc A; Rousseau A; Delluc C; Le Moigne E; Le Gal G; Mottier D; Van Dreden P; Lacut K
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):295-300. PubMed ID: 21372691
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.
Wun T; White RH
Cancer Invest; 2009; 27 Suppl 1():63-74. PubMed ID: 19291526
[TBL] [Abstract][Full Text] [Related]
5. Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics.
Paneesha S; McManus A; Arya R; Scriven N; Farren T; Nokes T; Bacon S; Nieland A; Cooper D; Smith H; O'Shaughnessy D; Rose P;
Thromb Haemost; 2010 Feb; 103(2):338-43. PubMed ID: 20024496
[TBL] [Abstract][Full Text] [Related]
6. [Frequency of venous thromboembolism among hospitalized patients with cancer].
Conte G; Figueroa G
Rev Med Chil; 2008 Dec; 136(12):1528-34. PubMed ID: 19350169
[TBL] [Abstract][Full Text] [Related]
7. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
[TBL] [Abstract][Full Text] [Related]
8. Occult cancer in patients with venous thromboembolism: which patients, which cancers.
Monreal M; Fernandez-Llamazares J; Perandreu J; Urrutia A; Sahuquillo JC; Contel E
Thromb Haemost; 1997 Nov; 78(5):1316-8. PubMed ID: 9408011
[TBL] [Abstract][Full Text] [Related]
9. [Place of cancer among the risk factors in venous thromboembolism].
Descourt R; Righini M; Carrier M; Le Gal G
Pathol Biol (Paris); 2008 Jun; 56(4):178-83. PubMed ID: 18325691
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
[TBL] [Abstract][Full Text] [Related]
12. Rates of venous thromboembolism occurrence in medical patients among the insured population.
Spyropoulos AC; Hussein M; Lin J; Battleman D
Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism and pancreatic cancer: incidence, pathogenesis and clinical implications.
Mandalà M; Moro C; Labianca R
Onkologie; 2008 Mar; 31(3):129-35. PubMed ID: 18322417
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
15. Influence of tumor stage, symptoms, and time of blood draw on serum concentrations of organochlorine compounds in exocrine pancreatic cancer.
Porta M; Pumarega J; López T; Jariod M; Marco E; Grimalt JO;
Cancer Causes Control; 2009 Dec; 20(10):1893-906. PubMed ID: 19562493
[TBL] [Abstract][Full Text] [Related]
16. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
17. Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer.
Dentali F; Malato A; Ageno W; Imperatori A; Cajozzo M; Rotolo N; Douketis J; Siragusa S; Crowther M
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):705-6. PubMed ID: 18329505
[No Abstract] [Full Text] [Related]
18. Role of anticoagulation in the management of pancreatic cancer.
Sohail MA; Saif MW
JOP; 2009 Mar; 10(2):82-7. PubMed ID: 19287098
[TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
20. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
